The Food and Drug Administration on Friday authorized the antiviral drug remdesivir as a treatment for some non-hospitalized adults and pediatric patients with mild to moderate COVID symptoms.

Why it matters: The move expands use of remdesivir, previously limited to only patients who were hospitalized, and comes as doctors face shortages of FDA-authorized treatments, per the Washington Post.

While the vaccine focus has centered around COVID, American teens and adults have missed out on tens of millions of other CDC recommended shots, a new analysis released exclusively to Axios shows.

Why it matters: It's yet another example of deferred preventative care during the pandemic — including kidney care and cancer screenings — which could ultimately turn into a major problem across the U.S. later.

President Biden acknowledged Wednesday that the U.S. should have done more COVID-19 testing earlier on during his first year in office.

Why it matters: The administration has faced criticism for the timing of the free tests that it distributed. A widespread shortage impacted millions across the country during the holidays as Omicron cases surged.

The White House said Friday a new website, COVIDTests.gov, will begin accepting orders Jan. 19 for free rapid tests shipped to Americans' homes.

Why it matters: The White House emphasized the importance of testing during the Omicron surge, with President Biden on Thursday announcing plans for the government to have 1 billion tests.

LGBTQ advocates and Congress members are calling on the Food and Drug Administration to revise its blood donor policy on sexually active gay and bisexual men as the country faces a blood shortage.

Why it matters: The FDA requires gay and bisexual men abstain from same-sex sexual activity for 90 days in order to donate blood.

The average cost of a single at-home rapid COVID test is about $12 in the U.S., more than twice the cost of a test in France and more than three times as much as in India.

The big picture: Places like Canada and the U.K. make tests available for free.

Robert Califf, President Biden's nominee to lead the FDA, is facing a surprisingly tight confirmation vote in the Senate.

Between the lines: A handful of Democrats have already announced their opposition to him over concerns about his drug industry ties or the FDA's record on the opioid epidemic, and several others may be on the fence.

• But abortion politics — not to mention the opportunity to sink a Biden nominee — are complicating efforts to make up for these defectors with Republican votes.

California Gov. Gavin Newsom on Monday proposed a plan to expand health care coverage to cover all low-income, undocumented Californians.

Why it matters: The proposal is part of the Democratic governor's $213 billion budget request for the 2022-23 fiscal year. If approved by the state legislature, it would begin no sooner than Jan. 1, 2024.

Most American businesses are holding back on requiring vaccines or testing for their employees. Now the U.S. Supreme Court is set to decide whether the Biden administration can force their hand.

Why it matters: Lives are at stake. And Omicron outbreaks are forcing business closures, flight cancellations and staffing shortages — a chaotic business environment that's not great for the economy or employers already struggling to attract workers.

Patrons will have to show proof of full vaccination to get into Chicago bars, restaurants, gyms and entertainment establishments that serve food or drinks starting Jan. 3.

Why it matters: More than a quarter of Chicagoans wouldn't currently qualify for entry under those rules. But at least one study shows the mandate could result in wider vaccination compliance.